109 filings
Page 2 of 6
8-K
5fp 5s2bvju16x4d
16 Jan 24
Carmell Corp Announces Addition of Dr. Jason D. Bloom to Scientific Advisory Board
6:01pm
8-K
i9z5nz9al9mrx2sm21
5 Jan 24
Departure of Directors or Certain Officers
4:39pm
8-K
epsz4vwaewa169gssf9w
15 Nov 23
Carmell Corp Announces Addition of Scott Frisch and Gilles Spenlehauer to Board of Directors
9:54pm
NT 10-Q
ppp47jh9f2vyv5 7o
15 Nov 23
Notice of late quarterly filing
4:56pm
8-K/A
0abtl
25 Oct 23
Unaudited Condensed Financial Statements
4:02pm
8-K
yzydj
6 Sep 23
Departure of Directors or Certain Officers
4:18pm
8-K/A
khuqioqz fa
14 Aug 23
Completion of Acquisition or Disposition of Assets
5:55pm
8-K
m5knqpjkd s0w6zq
14 Aug 23
Carmell Announces Successful Closing of Merger with Axolotl Biologix and Launch of a New Brand Identity
7:01am
8-K
m3k4ym9z3aygxb
1 Aug 23
Carmell Therapeutics Announces Merger with Axolotl Biologix, a Profitable Regenerative Medicine Company
4:39pm
8-K
3h5sxu
20 Jul 23
Entry into a Material Definitive Agreement
5:21pm
25-NSE
15u g9783
14 Jul 23
Exchange delisting
4:06pm
8-K
omt t3e4i
14 Jul 23
Other Events
11:50am
8-K
ztufesmmr4mgg
12 Jul 23
Submission of Matters to a Vote of Security Holders
12:00am
425
9pyrdi
10 Jul 23
Business combination disclosure
8:03am
8-K
jqdxgbq8xstm
10 Jul 23
Entry into a Material Definitive Agreement
8:00am
425
lr05us 6svz8
6 Jul 23
Business combination disclosure
5:15pm
8-K
yt5ft2nw8z
6 Jul 23
Other Events
5:11pm